Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2004, Vol. 9 ›› Issue (6): 658-661.

Previous Articles     Next Articles

Effects of pioglitazone on expression of myocardial proinflammatory cytokine in left ventricular hypertrophic rats

ZHANG Cheng, YE Ping, ZHANG Jie1   

  1. Department of Geriatric Cardiology, PLA General Hospital, BeiJing 100853, China;
    1The Second Clinic of National Defence University, Beijing 100856, China
  • Received:2004-03-09 Revised:2004-04-12 Published:2020-11-22

Abstract: AIM: To examine the effects of pioglitazone, an agonist of peroxisome proliferator-activated receptor γon the expression of proinflammatory cytokine in cardiac hypertrophic rats, and to examine the anti-inflammatory activities of this drug. METHODS: Hypertrophic cells were produced by abdominal aortic banding.Pioglitazone(20 mg·kg-1·d-1) was given orally 1 week before operation and continued till 4 weeks after operation, then the rats were killed, the heart was excised and weighed, and the mRNA expression of interleukin-1β and cardiotropin-1 were examined by RT-PCR.The protein of the two cytokines was examined by immunohistochemical analysis. RESULTS: Pioglitazone reduced the mRNA and protein expression of the two proinflammatory cytokines and inhibited the pressure overload-induced increase in the heart weight-to-body weight ratio. CONCLUSION: Pioglitazone may regulate cardiac hypertrophy through inhibiting the expression of proinflammatory cytokines.

Key words: peroxisome proliferator-activated receptor, cardiac hypertrophy, cytokine, thiazolidinedione, pioglitazone

CLC Number: